|
FY2018
12 months to Jul 31, 2018
|
FY2017
12 months to Jul 31, 2017
|
FY2016
12 months to Jul 31, 2016
|
FY2015
12 months to Jul 31, 2015
|
FY2014
12 months to Jul 31, 2014
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Non-cash Impairment charges | |||||
| Loss on extinguishment of debt | |||||
| Amortization of debt discounts and financing costs included in interest expense | |||||
| Stock-based compensation expense | |||||
| Allowance for excess and obsolete inventory | |||||
| Deferred income tax (benefit)/expense | |||||
| Flowchem | |||||
| Total deferred income tax (benefit)/expense | |||||
| Tax expense/(benefit) from stock-based awards | |||||
| Other | |||||
| Derivative fair value gain | |||||
| Debt repricing transaction costs | |||||
| Depreciation related to restructuring and realignment | |||||
| Gain on NFC acquisition | |||||
| Nagase Finechem Singapore (Pte) Ltd ("NFC") | |||||
| Total gain on NFC acquisition | |||||
| Gain on equipment disposition | |||||
| Changes in operating assets and liabilities, net of effects of acquisition | |||||
| Accounts receivable — trade | |||||
| Accounts receivable — other | |||||
| Inventories | |||||
| Other current and non-current assets | |||||
| Accounts payable | |||||
| Accrued liabilities and other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Additions to property, plant and equipment | |||||
| Additions to product registration intangibles | |||||
| Acquisition / Purchase, net of cash acquired | |||||
| Nagase Finechem Singapore (Pte) Ltd ("NFC") | |||||
| Sealweld | |||||
| Flowchem | |||||
| Other investing activities | |||||
| Proceeds from insurance claim | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from sale of common stock, net of issuance costs | |||||
| Principal payments on borrowings on term loan | |||||
| Tax expense/(benefit) from stock-based awards | |||||
| Debt repricing transaction costs | |||||
| Proceeds from term loan | |||||
| Deferred financing costs | |||||
| Net payments under credit facility | |||||
| Cash payments related to tax withholdings from stock-based awards | |||||
| Payment of dividends | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Other financing activities | |||||
| Net cash (used in)/provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at the beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash investing activities | |||||
| Purchase of property, plant and equipment through accounts payable | |||||
| Accrued liabilities under industrial lubricants business acquisition | |||||
Loading...